Recombinant Human EG-VEGF/PK1 Protein

Product Discontinued

Recombinant Human EG-VEGF/PK1 Protein Summary

• Description: Recombinant bioactive protein containing 86 amino acids for Human EG-VEGF/PK1
  
  

  Source:Mouse myeloma cell line
  Amino Acid Sequence:(P58294)

• Preparation Method: Determined to be >98% pure by SDS-PAGE
• Source: Nso cells
• Protein/Peptide Type: Recombinant Protein
• Gene: PROK1
• Purity: >98%, by SDS-PAGE
• Endotoxin Note: <0.1 ng/ug

Applications/Dilutions

• Dilutions:
  • SDS-Page
• Theoretical MW: 9.5 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

• Storage: Store at -20 to -80C. Avoid freeze-thaw cycles.
• Buffer: Lyophilized from PBS.
• Concentration: Lyoph
• Purity: >98%, by SDS-PAGE
• Reconstitution Instructions: Reconstitute in sterile PBS to a concentration of 0.1 - 1.0 mg/ml containing 0.1% BSA. This solution can then be diluted into other aqueous buffers.

Alternate Names for Recombinant Human EG-VEGF/PK1 Protein

• EGVEGF
• EG-VEGF
• EGVEGFblack mamba toxin-related protein
• Endocrine-gland-derived vascular endothelial growth factor
• Mambakine
• PK1mambakine
• PRK1prokineticin-1
• PROK1
• Prokineticin 1

Background

Human EG-VEGF (Endocrine-gland-derived Vascular endothelial growth factor) induces proliferation, migration and fenestration in capillary endothelial cells derived from endocrine glands. Recombinant EG-VEGF has a calculated molecular mass of approximately 9.5 kDa protein consisting of 86 amino acid residues.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: PROK1